Table 1.
Demographic and Clinical Characteristics of People With Human Immunodeficiency Virus in Clinical Care at 8 Sites Across the United States, March 2018–September 2022 (N = 7126)
| Characteristic | No. (%) |
|---|---|
| Age, y, mean (SD) | 48.92 (12.22) |
| Gender | |
| Male (cisgender) | 5532 (78) |
| Male (transgender) | 4 (0) |
| Female (cisgender) | 1449 (20) |
| Female (transgender) | 95 (1) |
| Not reported | 46 (1) |
| Ethnicity | |
| Hispanic or Latino/Latina | 853 (12) |
| Not Hispanic or Latino/Latina | 5718 (80) |
| Not reported | 555 (8) |
| Race | |
| White | 3305 (46) |
| Black | 3291 (46) |
| Other racial identity (eg, Asian, American Indian) | 401 (6) |
| Not reported | 129 (2) |
| Geographic location | |
| South | 3329 (47) |
| Northeast | 1628 (23) |
| West | 2169 (30) |
| Viral suppression | |
| Suppressed at all visits | 5764 (81) |
| Unsuppressed at any visit | 1362 (19) |
| Depression | |
| None/mild at all visits | 5336 (75) |
| Moderate/severe at any visit | 1790 (25) |
| SUD | |
| None/mild at all visits | 3612 (51) |
| Moderate/severe at any visit | 3514 (49) |
| Treatment for SUD | |
| Never received treatment | 6429 (90) |
| Received treatment at any visit | 697 (10) |
| Time on ART, y, median (IQR) | 9.5 (5–17) |
Data are presented as No. (%) unless otherwise indicated.
Abbreviations: ART, antiretroviral therapy; IQR, interquartile range; SD, standard deviation; SUD, substance use disorder.